Chinese biotech firm RecBio raises over $227.4m in Series B round

Chinese biotech firm RecBio raises over $227.4m in Series B round

Photo: National Cancer Institute/Unsplash

Eudora Wang

11 November, 2020

Legend CapitalRec-BiotechnologyRecBiovaccine

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.